Themis Medicare discloses submission of valuation report and updated compliance certificate for its proposed preferential allotment of convertible warrants.
The submission is in response to queries from BSE and NSE regarding the company's in-principle approval application.
This disclosure is made in compliance with SEBI Listing Regulations Regulation 30.
Board approval for the preferential allotment was granted on February 13, 2026.